With 2026 set to be a banner year for M&A as buyers facing patent cliffs compete for a limited pool of late-stage assets ( [3]) , companies demonstrating disciplined pivotal execution and FDA ...

Pfizer is steering much of its pandemic revenue into oncology, as Chief Executive Albert ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Providence Cancer Institute’s executive medical director ...

The most striking finding in recent oncological research is the significant gain in survival rates for cancers previously ...

Prostate cancer treatment is advancing rapidly. New pills and hormone treatments are giving patients better odds and a more comfortable experience. Doctors say Biden's diagnosis is a reminder to get ...

VANCOUVER, British Columbia, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Equity-Insider.comNews Commentary – The FDA approved the first perioperative immunotherapy for early gastric and gastroesophageal ...

The five-year survival rate for all cancers combined in the US reached a landmark 70% for Americans diagnosed between 2015 ...

Picture this: a breast cancer diagnosis that once meant endless cycles of harsh chemotherapy, now shifting toward smarter, more targeted therapies that attack cancer cells while sparing healthy ones.

Since 2018, more than $40 million has been granted to support outstanding cancer research projects by early-career scientists ...

Cancer diagnoses are both more common and more survivable than ever. The question is whether you can afford life-saving treatment.

Few issues in American politics have consistently united both parties like the fight against cancer. While funding levels and strategies may differ, Democrats and Republicans alike recognize that ...